The market for peptides, chemicals gaining popularity as medical treatments and wellness products, witnessed significant development. A divided Food and Drug Administration (FDA) panel recently voted to recommend easing regulations on six peptide treatments.
The FDA will need time to incorporate the committee’s recommendations before making a final decision. This process may take months as the agency carefully examines the potential impacts and benefits of these treatments.
Local Coalition Fights to Keep Maine Birthing Unit Open 
Financial Assistance for Fertility Treatment: Grants, Costs, and Options 
Rising Threat of Drug-Resistant Candida Auris in the U.S. 
Impact of Extreme Heat on Flight Operations 
Beware Fake Party Invitations: Tips to Protect Your Computer 
FDA Permits Zyn Nicotine Pouches as Lower Risk Alternative to Cigarettes